Anxiety and depressive symptoms and missing breast cancer and cervical screening: results from Brazos valley community health survey

Zhang, Xiaoying; Mkuu, Rahma; Samman, Elfreda; Cummings, Shelby; Sherman, Ledric D; Wigfall, Lisa T.; Wilkinson, Larrell L.; Burdine, James N.

doi:10.1080/13548506.2019.1668031

Cited by 7 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Existing studies have been conducted mainly in developed countries, with different incidence of cervical cancer and experience related to cervical cancer screening, which significantly complicates the comparison of results. Besides, since the present study and others cited seem to have included women who are attending clinic and receiving guideline‐concordant care, consequently the research only included women who did participate in follow‐up protocols that probably led to an underestimation of women's depression 39,40 …”

Section: Discussionmentioning

confidence: 99%

“…Besides, since the present study and others cited seem to have included women who are attending clinic and receiving guideline-concordant care, consequently the research only included women who did participate in follow-up protocols that probably led to an underestimation of women's depression. 39,40 The existence of depressive symptoms before, and persistence after diagnostic procedures, makes it necessary to identify the group of women at risk in order to provide adequate information and counseling to reduce psychological distress in women with a positive Papanicolaou smear screening test. [41][42][43] Adequate adherence to diagnostic procedures would help to reduce the percentage of invasive cervical cancer, when survival is significantly lower than in earlier stages of the disease, and reduce treatment costs.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test

et al. 2022

View full text Add to dashboard Cite

Background Some studies did find significant differences in the level of depression of women while undergoing diagnostic evaluation of an abnormal Papanicolaou screening smear, but findings were not consistent. This study aimed to assess prevalence and correlates of depression in women with abnormal cervical screening results before and after diagnostic procedures. Methods A cross‐sectional study was carried out during 2017 in a cohort of women with positive Papanicolaou screening test before and after diagnostic procedures (colposcopy/biopsy/endocervical curettage) at the university Clinical Centre Kragujevac, Serbia. Women completed a questionnaire about demographics, lifestyle, and other factors of interest. Also, questionnaire “Hospital Anxiety and Depression Scale” (HADS) was used immediately before and 2–4 weeks after the diagnostic procedures: a score of ≥8 on HADS‐D and HADS‐A subscales indicated depression and anxiety, respectively. Multivariate logistic regression was applied in the data analysis. Results The study comprised 172 women, giving a response rate of 72.3%. The mean age of the participants was 47.8 ± 11.1 years (range 23–65). The frequency of depressive symptoms was significantly higher after diagnostic procedures (48.3%) than before diagnostic procedures (37.2%) (p = 0.038). Before diagnostic procedures, older age (OR = 1.60; 95% CI = 1.09–2.34; p = 0.017), and level of anxiety according to the HADS‐A subscale (OR = 1.61; 95% CI = 1.38–1.88; p < 0.001) were significant independent predictors of depression. After diagnostic procedures, significant independent predictors of depression were urban place of residence (OR = 0.12; 95% CI = 0.03–0.47; p = 0.002) and level of anxiety according to the HADS‐A subscale (OR = 1.85; 95% CI = 1.54–2.21; p < 0.001). Conclusion Our study showed that older age, rural residence, and anxiety play a role in shaping the risk of depression among women undergoing additional diagnostic procedures after receiving an abnormal Papanicolaou screening result.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Previous literature has demonstrated the association between mental illnesses such as schizophrenia and bipolar disorder and cancer screening. There was a limited number of studies examining the association between anxiety and depression and cancer screening behavior [10]. Because of increasing evidence of disparities in disease-specifıc morbidity and mortality in mentally ill patients, there is a growing need to understand the impact of mental illness as a barrier to cancer screening [11][12][13][14].…”

Section: Introductionmentioning

confidence: 99%

Association of missed cervical cancer screening with sociodemographic characteristics and depression in women age 25-64 years

Milijasevic¹,

Susnjevic²,

Ukropina³

et al. 2022

Hosp Pharm Int Multi J

View full text Add to dashboard Cite

Introduction: There is evidence that cancer screening and similar health interventions in patients with mental illnesses in some countries remain suboptimal. Considering the high prevalence of depression among women in Vojvodina, this study aimed to estimate the association of reduced utilization of cervical screening tests with sociodemographic variables and with depression. Aim: Considering the high prevalence of depression among women in Vojvodina, this study aimed to estimate the association of reduced utilization of cervical screening tests with sociodemographic variables and with depression. Material and Methods: The study was conducted as a cross-sectional study on 1,226 women age 25-64 years from the Province of Vojvodina, as a part of the National Health Survey. To determine the impact of the time when the last smearing test was done (as a dependent variable) on sociodemographic characteristics and depression binary logistic regression model (Enter) was implemented. Models were adjusted for age, type of settlement, education, material status (wealth index), employment status, having a gynecologist in stateowned and private practice, and depression. Results: Out of the total, 555 women (59.7%) missed the cervical smear test in the last 12 months. Women with a secondary school were more likely to miss the cervical smear test in the last 12 months (OR=1.62; 95% CI=1.13-2.33) as well as women age 50-64 years (OR=1.45; 95% CI=0.99-2.13). Women without gynecologist in either a state-owned or private health practice had 4.13 and 2.20 higher odds of not done cervical smear tests during the last 12 months. Conclusion: The results show that special attention should be paid by physicians to identifying disorders in women, which can lead to neglect of their health, and reduced health control.

show abstract

“…Specifically, for each person who ever met the case definition for a psychiatric disorder based on administrative health data, annually we determined whether the condition was active or inactive [ 15 ]. We reasoned that the effects of a psychiatric disorder would occur mainly when the disorder was active (symptomatic) [ 16 – 18 ], potentially due to factors such as lack of interest, suicidal ideation, avoidance, cognitive effects, or other mechanisms.…”

Section: Introductionmentioning

confidence: 99%

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease

et al. 2021

View full text Add to dashboard Cite

We aimed to examine rates of breast and cervical cancer screening in women with immune-mediated inflammatory diseases (IMID), including inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA) versus a matched cohort with IMID; and examine the association of psychiatric comorbidity with screening in these populations. We conducted a retrospective cohort study in Manitoba, Canada using administrative data. We identified women with IBD, MS and RA, and controls without these IMID matched on age and region. Annually, we identified individuals with any active mood/anxiety disorder. Using physician claims, we determined the proportion of each cohort who had cervical cancer screening within three-year intervals, and mammography screening within two-year intervals. We modeled the difference in the proportion of the IMID and matched cohorts who underwent mammography; and pap tests using log-binomial regression with generalized estimating equations, adjusting for sociodemographics, comorbidity and immune therapy use. We tested for additive interactions between cohort and mood/anxiety disorder status. During 2006–2016, we identified 17,230 women with IMID (4,623 with IBD, 3,399 with MS, and 9,458 with RA) and 85,349 matched controls. Having an IMID was associated with lower (-1%) use of mammography; however, this reflected a mixture of more mammography in the IBD cohort (+2.9%) and less mammography in the MS (-4.8 to -5.2%) and RA (-1.5%) cohorts. Within the IBD, MS and RA cohorts, having an active mood/anxiety disorder was associated with more mammography use than having an inactive mood/anxiety disorder. The MS and RA cohorts were less likely to undergo Pap testing than their matched cohorts. In the absence of an active mood/anxiety disorder, the IBD cohort was more likely to undergo Pap testing than its matched cohort; the opposite was true when an active mood/anxiety disorder was present. Among women with an IMID, mood/anxiety disorder influence participation in cancer screening.

show abstract

Anxiety and depressive symptoms and missing breast cancer and cervical screening: results from Brazos valley community health survey

Cited by 7 publications

References 23 publications

Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test

Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test

Association of missed cervical cancer screening with sociodemographic characteristics and depression in women age 25-64 years

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease

Contact Info

Product

Resources

About